Strandline Resources has announced plans to sell its Tanzanian assets to China-based Ganzhou Chenguang Rare Earths New Material Company in a $43 million consideration package.
Recent rallies in Perth and across the country against gender-based violence serve as a demonstration of the level of community concern about the issue.
Perth had the highest annual growth in the median price of residential land among Australian capital cities in 2023, according to a property industry report.
A former public health employee found by the Corruption and Crime Commission to have siphoned more than $280,000 is facing 52 charges related to corruption.
Shares in Wangara-based contractor Duratec Australia dipped early following news it had revised its annual guidance for the 2024 financial year, citing delays in the tender process for several projects.
MCT Equipment and CME Boilermaking Services proudly announce the launch of Magni by LIFTR, unveiling the HTH 16.10U heavy telehandler, purpose-built for the toughest mining environments.
A new Deloitte report has highlighted Australia’s “she’ll be right” attitude towards generative AI risks the nation falling behind our neighbours in the Asia-Pacific region.
A Joondalup-based medical cannabis producer is moving to capitalise on Germany’s recent decriminalisation of the drug, outlining plans to merge with one of Europe’s largest cannabis manufacturers.
Resources heavyweight BHP has backed two organisations in the Pilbara, one to support people experiencing family and domestic violence and another aiding health outcomes of Indigenous children.
Mark Beyer and Mark Pownall discuss the federal budget’s mining support, Santos and Quintis job cuts, live sheep exports, property development approvals, NWQ Capital Management, and Clough's journey under Peter Bennett.
Rival fund managers are perplexed by the scale of the debt left by NWQ Capital Management, expressing surprise at the almost $20 million owed, including to four prominent Perth business figures.
Innovation hub Spacecubed has signed an MoU with one of India’s largest Medtech precincts, aimed at exploring collaborative opportunities for high-growth Medtech startups.
Shares in Claremont-based PharmAust rose 5 per cent early on Friday morning, following news the company had received orphan drug designation for both monepantel and the treatment of motor neurone disease and amyotrophic lateral sclerosis.